Hints and tips:
Related Special Reports
...But according to research commissioned by the BGMA and carried out by Europe Economics and RFW Associates, two consultancies, for each company deterred from launching a biosimilar, the cost to the health...
...Horizon, Britain will pay no financial contributions for the first three years of the programme, which runs from 2021 to 2027 and involves more than 40 countries working in areas from climate change and medicines...
...Amazon is being threatened with legal action from the US medicines watchdog over the sales of “unapproved” drugs on its online site, as the tech giant faces scrutiny while seeking to break further into the...
...Intas has since resumed supply of oncology drugs to the US but Valerie Jensen, associate director of the FDA’s drug shortages staff, says the company and its competitors have not been able to ramp up capacity...
...The fungus then grows in the lungs, normally in people with depressed immunity or existing pulmonary problems....
...In the view of Neil Ross, associate director of policy at trade group TechUK, it will take five to 10 years of concentrated action to get there....
...Yet she initially went down a different path, applying to study medicine in Paris. “I was always interested in maths and science,” she says....
...That made it more potent than Wegovy, said Fatima Cody Stanford, an obesity medicine physician and associate professor at Harvard Medical School and Massachusetts General Hospital....
...“These variants were giving [ancient] people an advantage of some kind,” said William Barrie, co-author of the MS paper and a research associate at Cambridge university....
...associate professor at Harvard Medical School and Massachusetts General Hospital....
...I huffed repeatedly into spirometers to gauge my pulmonary function, and squeezed mightily over and over on a grip-strength dynamometer. I dispensed many, many vials of blood....
...The re-establishment of Horizon relationships offers an opportunity to be more strategic than the “pandemonium” of applications seen pre-Brexit, argued Sir John Bell, regius professor of medicine at Oxford...
...Insilico Medicine, which was founded by Latvian-born scientist Alex Zhavoronkov, said it had dosed a patient in China with a novel therapy to treat the chronic lung disease idiopathic pulmonary fibrosis....
...Sarah O’Connor, you’re associate editor and a columnist at the FT....
...The €95.5bn Horizon multilateral research programme is the world’s largest, involving more than 40 countries and covering areas from climate change to new medicines and artificial intelligence....
...On a table in his superb portrait of Paul Gachet, Auvers’ friendly doctor, he painted what he describes as a dark purple foxglove, relevant, I assume, to Gachet’s herbal medicine chest....
...Last year, sales of GSK’s drug for severe asthma, Nucala, rose 25 per cent to £1.4bn, while revenue from Trelegy, a treatment for asthma and chronic obstructive pulmonary disease, soared 42 per cent to £1.7bn...
...In May, having gone into hospital for a knee operation, Abramović suffered a pulmonary embolism that nearly killed her....
...About 3,000 pharmacists will learn to prescribe medicines for common ailments, easing pressure on clinical staff....
...Martin Jes Iversen, an associate professor of strategy and innovation at Copenhagen Business School, says the structure kept the company committed to its broader purpose beyond profitability....
...He purchased the medicine via Roivant, his drug development group, before creating a subsidiary named Axovant to develop it....
...the demands of China’s developing healthcare system, Wang has overseen the building of thousands of centres within hospitals to deliver AstraZeneca’s Pulmicort, a drug for asthma and chronic obstructive pulmonary...
...“It’s like tobacco,” says Graham MacGregor, professor of cardiovascular medicine at the Wolfson Institute, Queen Mary University of London....
...Chris Meekins, analyst at Raymond James & Associates, said Merck was the first but probably not the last big drugmaker that would challenge the government....
...Insilico Medicine’s therapy aims to treat the chronic lung disease idiopathic pulmonary fibrosis. For up-to-the-minute news updates, visit our live blog Good evening....
International Edition